Saltar al contenido
Merck

Effect of Wnt inhibitors in pancreatic cancer.

Anticancer research (2014-10-03)
Ilona Wall, Ingo G H Schmidt-Wolf
RESUMEN

Activated Wnt signaling in cancer cells leads to cell proliferation. It has been shown that the Wnt pathway is activated in pancreatic adenocarcinoma cells. Therefore, we tested the effect of Wnt inhibitors in human and murine pancreatic cancer cell lines. The Wnt inhibitors ethacrynic acid (EA), ciclopirox olamine (CIC), piroctone olamine (PO) and griseofulvin (GF) were tested in murine and human pancreatic cancer cell lines with the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. We showed that the Wnt inhibitors significantly reduced cell viability in murine, as well as human pancreatic cancer cell lines. These results may lead to a new therapeutic option with Wnt inhibitors for patients with pancreatic adenocarcinoma.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Piroctone olamine, analytical standard, PESTANAL®
Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard
Ciclopirox, European Pharmacopoeia (EP) Reference Standard
Etacrynic acid for system suitability, European Pharmacopoeia (EP) Reference Standard